SAN FRANCISCO -- Herculean efforts by scientists and physicians around the world have resulted more than 50 experimental COVID-19 vaccines currently in global clinical trials. The focus in the U.S.
Hosted on MSN
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca
Shares of Moderna (MRNA), Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt future mRNA vaccine development under the ...
The European Medicines Agency (EMA) could issue an opinion on the COVID-19 vaccine co-developed by AstraZeneca and the University of Oxford as early as 29 January, according to a press release the ...
Wall Street’s major market averages ended near even on Friday as traders digested the latest round of key retail inflation data. The blue-chip Dow ended +0.1%. At the same time, the benchmark S&P 500 ...
LONDON -AstraZeneca is paying up to $157 million, plus royalties, for an exclusive licence to develop and sell a set of ...
The AstraZeneca jab is no longer recommended for people aged under 60 after new expert immunisation panel advice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results